In 2025, the ethical implications of using AI for drug discovery in the US will center on data privacy, algorithmic bias, job displacement, access equity, and regulatory oversight, requiring careful consideration by stakeholders. The use of artificial intelligence (AI) in drug discovery holds immense promise for accelerating the development of new and life-saving treatments. However, […]